Ethiopia faces an epidemic among subpopulations and geographic areas, with an estimated overall HIV prevalence rate between 0.9 and 2.5 percent among people aged 15 to 49. HIV/AIDS remains one of the key challenges for the overall development of Ethiopia, as it has led to a 7-year decrease in life expectancy and a greatly reduced workforce. In FY 2007, USAID/Ethiopia allocated $38 million for antiretroviral drugs and $11 million for laboratory infrastructure to be used for detecting and treating HIV/AIDS.

This audit will (1) determine whether selected USAID/Ethiopia implementing partners have procured, warehoused, and disseminated commodities to help ensure that intended results are achieved and (2) assess the activities’ impact.

Source:  Office of Inspector General ANNUAL PLAN FISCAL YEAR 2009